Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1997 Apr 15;323(Pt 2):329–335. doi: 10.1042/bj3230329

A nonsense mutation in the 3-hydroxy-3-methylglutaryl-CoA lyase gene produces exon skipping in two patients of different origin with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

J Pié 1, N Casals 1, C H Casale 1, C Buesa 1, C Mascaró 1, A Barceló 1, M O Rolland 1, T Zabot 1, D Haro 1, F Eyskens 1, P Divry 1, F G Hegardt 1
PMCID: PMC1218323  PMID: 9163320

Abstract

A novel nonsense mutation associated with the skipping of constitutive exon 2 of the 3-hydroxy-3-methylglutaryl-CoA lyase gene was found in two patients, from Portugal and Morocco, with 3-hydroxy-3-methylglutaric acidemia. By reverse transcriptase PCR and single-strand conformational polymorphism a G-T transversion was located, at nucleotide 109, of the 3-hydroxy-3-methylglutaryl-CoA lyase cDNA, within exon 2. Two mRNAs were produced as a result of this nonsense mutation: one of the expected size that contains the premature stop codon UAA, and the other with a deletion of 84 bp corresponding to the whole of exon 2. This deletion produced the loss of the last seven amino acids of the leader peptide and the first 21 amino acids of the mature protein. The nonsense mutation was found in a purine-rich GGAAG sequence, which is equal to, or similar to, others reported to be exonic splicing enhancers (ESE). We suggest that the nonsense mutation may affect a possible ESE on exon 2, which would hinder the splice site selection and facilitate an aberrant splice with the skipping of this exon. Determination by quantitative PCR shows that the ratio of mRNA with the nonsense mutation to the mRNA with the deletion is approx. 3:1.

Full Text

The Full Text of this article is available as a PDF (457.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amendt B. A., Si Z. H., Stoltzfus C. M. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol Cell Biol. 1995 Aug;15(8):4606–4615. doi: 10.1128/mcb.15.8.4606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson D. H., Rodwell V. W. Nucleotide sequence and expression in Escherichia coli of the 3-hydroxy-3-methylglutaryl coenzyme A lyase gene of Pseudomonas mevalonii. J Bacteriol. 1989 Dec;171(12):6468–6472. doi: 10.1128/jb.171.12.6468-6472.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belgrader P., Maquat L. E. Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping. Mol Cell Biol. 1994 Sep;14(9):6326–6336. doi: 10.1128/mcb.14.9.6326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berget S. M. Exon recognition in vertebrate splicing. J Biol Chem. 1995 Feb 10;270(6):2411–2414. doi: 10.1074/jbc.270.6.2411. [DOI] [PubMed] [Google Scholar]
  5. Buesa C., Pié J., Barceló A., Casals N., Mascaró C., Casale C. H., Haro D., Duran M., Smeitink J. A., Hegardt F. G. Aberrantly spliced mRNAs of the 3-hydroxy-3-methylglutaryl coenzyme A lyase (HL) gene with a donor splice-site point mutation produce hereditary HL deficiency. J Lipid Res. 1996 Nov;37(11):2420–2432. [PubMed] [Google Scholar]
  6. Dallman M. J., Montgomery R. A., Larsen C. P., Wanders A., Wells A. F. Cytokine gene expression: analysis using northern blotting, polymerase chain reaction and in situ hybridization. Immunol Rev. 1991 Feb;119:163–179. doi: 10.1111/j.1600-065x.1991.tb00583.x. [DOI] [PubMed] [Google Scholar]
  7. Dibb N. J. Why do genes have introns? FEBS Lett. 1993 Jun 28;325(1-2):135–139. doi: 10.1016/0014-5793(93)81429-4. [DOI] [PubMed] [Google Scholar]
  8. Dietz H. C., Valle D., Francomano C. A., Kendzior R. J., Jr, Pyeritz R. E., Cutting G. R. The skipping of constitutive exons in vivo induced by nonsense mutations. Science. 1993 Jan 29;259(5095):680–683. doi: 10.1126/science.8430317. [DOI] [PubMed] [Google Scholar]
  9. Dirksen W. P., Sun Q., Rottman F. M. Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J Biol Chem. 1995 Mar 10;270(10):5346–5352. doi: 10.1074/jbc.270.10.5346. [DOI] [PubMed] [Google Scholar]
  10. Endo F., Awata H., Katoh H., Matsuda I. A nonsense mutation in the 4-hydroxyphenylpyruvic acid dioxygenase gene (Hpd) causes skipping of the constitutive exon and hypertyrosinemia in mouse strain III. Genomics. 1995 Jan 1;25(1):164–169. doi: 10.1016/0888-7543(95)80122-3. [DOI] [PubMed] [Google Scholar]
  11. Faull K. F., Bolton P. D., Halpern B., Hammond J., Danks D. M. The urinary organic acid profile associated with 3-hydroxy-3-methylglutaric aciduria. Clin Chim Acta. 1976 Dec;73(3):553–559. doi: 10.1016/0009-8981(76)90160-1. [DOI] [PubMed] [Google Scholar]
  12. Gibson K. M., Breuer J., Kaiser K., Nyhan W. L., McCoy E. E., Ferreira P., Greene C. L., Blitzer M. G., Shapira E., Reverte F. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: report of five new patients. J Inherit Metab Dis. 1988;11(1):76–87. doi: 10.1007/BF01800058. [DOI] [PubMed] [Google Scholar]
  13. Gibson K. M., Breuer J., Nyhan W. L. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients. Eur J Pediatr. 1988 Dec;148(3):180–186. doi: 10.1007/BF00441397. [DOI] [PubMed] [Google Scholar]
  14. Gibson K. M., Cassidy S. B., Seaver L. H., Wanders R. J., Kennaway N. G., Mitchell G. A., Spark R. P. Fatal cardiomyopathy associated with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency. J Inherit Metab Dis. 1994;17(3):291–294. doi: 10.1007/BF00711810. [DOI] [PubMed] [Google Scholar]
  15. Humphrey M. B., Bryan J., Cooper T. A., Berget S. M. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5' splice sites in a differential internal exon. Mol Cell Biol. 1995 Aug;15(8):3979–3988. doi: 10.1128/mcb.15.8.3979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kramer P. R., Miziorko H. M. Purification and characterization of avian liver 3-hydroxy-3-methylglutaryl coenzyme A lyase. J Biol Chem. 1980 Nov 25;255(22):11023–11028. [PubMed] [Google Scholar]
  17. Mitchell G. A., Jakobs C., Gibson K. M., Robert M. F., Burlina A., Dionisi-Vici C., Dallaire L. Molecular prenatal diagnosis of 3-hydroxy-3-methylglutaryl CoA lyase deficiency. Prenat Diagn. 1995 Aug;15(8):725–729. doi: 10.1002/pd.1970150807. [DOI] [PubMed] [Google Scholar]
  18. Mitchell G. A., Robert M. F., Hruz P. W., Wang S., Fontaine G., Behnke C. E., Mende-Mueller L. M., Schappert K., Lee C., Gibson K. M. 3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL). Cloning of human and chicken liver HL cDNAs and characterization of a mutation causing human HL deficiency. J Biol Chem. 1993 Feb 25;268(6):4376–4381. [PubMed] [Google Scholar]
  19. Naylor J. A., Green P. M., Rizza C. R., Giannelli F. Analysis of factor VIII mRNA reveals defects in everyone of 28 haemophilia A patients. Hum Mol Genet. 1993 Jan;2(1):11–17. doi: 10.1093/hmg/2.1.11. [DOI] [PubMed] [Google Scholar]
  20. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  21. Ozand P. T., al Aqeel A., Gascon G., Brismar J., Thomas E., Gleispach H. 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia. J Inherit Metab Dis. 1991;14(2):174–188. doi: 10.1007/BF01800590. [DOI] [PubMed] [Google Scholar]
  22. Ramchatesingh J., Zahler A. M., Neugebauer K. M., Roth M. B., Cooper T. A. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol. 1995 Sep;15(9):4898–4907. doi: 10.1128/mcb.15.9.4898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Roberts J. R., Narasimhan C., Hruz P. W., Mitchell G. A., Miziorko H. M. 3-Hydroxy-3-methylglutaryl-CoA lyase: expression and isolation of the recombinant human enzyme and investigation of a mechanism for regulation of enzyme activity. J Biol Chem. 1994 Jul 8;269(27):17841–17846. [PubMed] [Google Scholar]
  24. Roberts J. R., Narasimhan C., Miziorko H. M. Evaluation of cysteine 266 of human 3-hydroxy-3-methylglutaryl-CoA lyase as a catalytic residue. J Biol Chem. 1995 Jul 21;270(29):17311–17316. doi: 10.1074/jbc.270.29.17311. [DOI] [PubMed] [Google Scholar]
  25. Robinson A. M., Williamson D. H. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev. 1980 Jan;60(1):143–187. doi: 10.1152/physrev.1980.60.1.143. [DOI] [PubMed] [Google Scholar]
  26. Salomon R. N., Underwood R., Doyle M. V., Wang A., Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2814–2818. doi: 10.1073/pnas.89.7.2814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sovik O., Sweetman L., Gibson K. M., Nyhan W. L. Genetic complementation analysis of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency in cultured fibroblasts. Am J Hum Genet. 1984 Jul;36(4):791–801. [PMC free article] [PubMed] [Google Scholar]
  29. Staffa A., Cochrane A. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol Cell Biol. 1995 Aug;15(8):4597–4605. doi: 10.1128/mcb.15.8.4597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sun Q., Mayeda A., Hampson R. K., Krainer A. R., Rottman F. M. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 1993 Dec;7(12B):2598–2608. doi: 10.1101/gad.7.12b.2598. [DOI] [PubMed] [Google Scholar]
  31. Wang S. P., Robert M. F., Gibson K. M., Wanders R. J., Mitchell G. A. 3-Hydroxy-3-methylglutaryl CoA lyase (HL): mouse and human HL gene (HMGCL) cloning and detection of large gene deletions in two unrelated HL-deficient patients. Genomics. 1996 Apr 1;33(1):99–104. doi: 10.1006/geno.1996.0164. [DOI] [PubMed] [Google Scholar]
  32. Wang S., Nadeau J. H., Duncan A., Robert M. F., Fontaine G., Schappert K., Johnson K. R., Zietkiewicz E., Hruz P., Miziorko H. 3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL): cloning and characterization of a mouse liver HL cDNA and subchromosomal mapping of the human and mouse HL genes. Mamm Genome. 1993;4(7):382–387. doi: 10.1007/BF00360589. [DOI] [PubMed] [Google Scholar]
  33. Watakabe A., Tanaka K., Shimura Y. The role of exon sequences in splice site selection. Genes Dev. 1993 Mar;7(3):407–418. doi: 10.1101/gad.7.3.407. [DOI] [PubMed] [Google Scholar]
  34. Wysocki S. J., Hähnel R. 3-Hydroxy-3-methylglutaryl-coenzyme a lyase deficiency: a review. J Inherit Metab Dis. 1986;9(3):225–233. doi: 10.1007/BF01799652. [DOI] [PubMed] [Google Scholar]
  35. Xu R., Teng J., Cooper T. A. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol Cell Biol. 1993 Jun;13(6):3660–3674. doi: 10.1128/mcb.13.6.3660. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES